申请人:Takeda Chemical Industries, Ltd.
公开号:EP1437351A1
公开(公告)日:2004-07-14
The present invention provide a compound of the formula:
wherein X and X' are the same or different and each represents a hydrogen atom, etc.; R1 and R2 are the same or different and each represents a hydrogen atom, etc.; R3 represents a hydrocarbon group optionally having substituents, etc.; R4 represents a hydrogen atom, etc.; Y and Ya are the same or different and each represents a bond or a spacer having a main chain of 1 to 8 atoms; Z and Za are the same or different and each represents a hydrogen atom, etc.; or a salt thereof or a prodrug thereof, having a somatostatin receptor binding inhibitory activity and is useful for preventing and/or treating diseases associated with somatostatin.
本发明提供一种式的化合物:
其中X和X'相同或不同,各自代表氢原子等;R1和R2相同或不同,各自代表氢原子等;R3代表任选具有取代基的烃基等;R4代表氢原子等。Y和Ya相同或不同,各自代表键或具有1至8个原子的主链的间隔物;Z和Za相同或不同,各自代表氢原子等;或其盐或其原药,具有抑制体生长抑素受体结合的活性,可用于预防和/或治疗与体生长抑素相关的疾病。